Cell replacement therapies to promote remyelination in a viral model of demyelination

Journal of Neuroimmunology

Volumn 224, Issue 1-2, 2010, Pages 101-107

  Tirotta, Emanuele ^a   Carbajal, Kevin S ^a   Schaumburg, Chris S ^a   Whitman, Lucia ^a   Lane, Thomas E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal models; Demyelination; Neuroinflammation; Repair; Stem cells

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

CELL DIFFERENTIATION; CELL MIGRATION; CORONAVIRUS INFECTION; DEMYELINATING DISEASE; EMBRYONIC STEM CELL; ENGRAFTMENT; HUMAN; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; MURINE HEPATITIS CORONAVIRUS; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLIGODENDROGLIA; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REMYELINIZATION; REVIEW; STEM CELL TRANSPLANTATION; ANIMAL; CELL LINEAGE; CORONAVIRUS INFECTIONS; DEMYELINATING DISEASES; DISEASE MODEL; ENCEPHALITIS, VIRAL; IMMUNOLOGY; METABOLISM; MOUSE; MYELINATED NERVE; NERVE REGENERATION; PATHOLOGY; PROCEDURES; TRENDS; VIROLOGY;

ANIMALS; CELL LINEAGE; CORONAVIRUS INFECTIONS; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; HUMANS; MICE; MURINE HEPATITIS VIRUS; NERVE FIBERS, MYELINATED; NERVE REGENERATION; STEM CELL TRANSPLANTATION;

EID: 77955089176     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.05.013     Document Type: Review

References (74)

1. Aharonowiz M., Einstein O., Fainstein N., Lassmann H., Reubinoff B., Ben-Hur T. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One 2008, 3:e3145.
2. Akesson E., Wolmer-Solberg N., Cederarv M., Falci S., Odeberg J. Human neural stem cells and astrocytes, but not neurons, suppress an allogeneic lymphocyte response. Stem Cell Res 2009, 2:56-67.
3. Akiyama Y., Radtke C., Kocsis J.D. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 2002, 22:6623-6630.
4. Amariglio N., Hirshberg A., Scheithauer B.W., Cohen Y., Loewenthal R., Trakhtenbrot L., Paz N., Koren-Michowitz M., Waldman D., Leider-Trejo L., Toren A., Constantini S., Rechavi G. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009, 6:e1000029.
5. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007, 61:288-299.
6. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 2007, 61:504-513.
7. Beech J.S., Wheeler D.W., Reckless J., Grant A.J., Price J., Mastroeni P., Grainger D.J., Menon D.K. The MHP36 line of murine neural stem cells expresses functional CXCR1 chemokine receptors that initiate chemotaxis in vitro. J Neuroimmunol 2007, 184:198-208.
8. Ben-Hur T., Rogister B., Murray K., Rougon G., Dubois-Dalcq M. Growth and fate of PSA-NCAM+precursors of the postnatal brain. J Neurosci 1998, 18:5777-5788.
9. Bergmann C.C., Lane T.E., Stohlman S.A. Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol 2006, 4:121-132.
10. Blakemore W.F., Irvine K.A. Endogenous or exogenous oligodendrocytes for remyelination. J Neurol Sci 2008, 265:43-46.
11. Brustle O., Jones K.N., Learish R.D., Karram K., Choudhary K., Wiestler O.D., Duncan I.D., McKay R.D. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999, 285:754-756.
12. Brustle O., Jones K.N., Learish R.D., Karram K., Choudhary K., Wiestler O.D., Duncan I.D., McKay R.D. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999, 285:754-756.
13. Cao Q., Benton R.L., Whittemore S.R. Stem cell repair of central nervous system injury. J Neurosci Res 2002, 68:501-510.
14. Dziembowska M., Tham T.N., Lau P., Vitry S., Lazarini F., Dubois-Dalcq M. A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 2005, 50:258-269.
15. Ebers G.C., Sadovnick A.D., Risch N.J. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 1995, 377:150-151.
16. Einstein O., Grigoriadis N., Mizrachi-Kol R., Reinhartz E., Polyzoidou E., Lavon I., Milonas I., Karussis D., Abramsky O., Ben-Hur T. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp Neurol 2006, 198:275-284.
17. Fleming J.O., Trousdale M.D., el-Zaatari F.A., Stohlman S.A., Weiner L.P. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 1986, 58:869-875.
18. Franklin R.J. Why does remyelination fail in multiple sclerosis?. Nat Rev Neurosci 2002, 3:705-714.
19. Glass W.G., Hickey M.J., Hardison J.L., Liu M.T., Manning J.E., Lane T.E. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol 2004, 172:4018-4025.
20. Glass W.G., Liu M.T., Kuziel W.A., Lane T.E. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology 2001, 288:8-17.
21. Gordon R.J., McGregor A.L., Connor B. Chemokines direct neural progenitor cell migration following striatal cell loss. Mol Cell Neurosci 2009, 41:219-232.
22. Grinnemo K.H., Kumagai-Braesch M., Mansson-Broberg A., Skottman H., Hao X., Siddiqui A., Andersson A., Stromberg A.M., Lahesmaa R., Hovatta O., Sylven C., Corbascio M., Dellgren G. Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online 2006, 13:712-724.
23. Guan Y., Jiang Z., Ciric B., Rostami A.M., Zhang G.X. Upregulation of chemokine receptor expression by IL-10/IL-4 in adult neural stem cells. Exp Mol Pathol 2008, 85:232-236.
24. Halfpenny C., Benn T., Scolding N. Cell transplantation, myelin repair, and multiple sclerosis. Lancet Neurol 2002, 1:31-40.
25. Hardison J.L., Nistor G., Gonzalez R., Keirstead H.S., Lane T.E. Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response. Exp Neurol 2006, 197:420-429.
26. Hatch M.N., Schaumburg C.S., Lane T.E., Keirstead H.S. Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis. J Neuroimmunol 2009, 212:74-81.
27. Herndon R.M., Griffin D.E., McCormick U., Weiner L.P. Mouse hepatitis virus-induced recurrent demyelination. A preliminary report. Arch Neurol 1975, 32:32-35.
28. Hori J., Ng T.F., Shatos M., Klassen H., Streilein J.W., Young M.J. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003, 21:405-416.
29. Hori J., Ng T.F., Shatos M., Klassen H., Streilein J.W., Young M.J. Neural progenitor cells lack immunogenicity and resist destruction as allografts. 2003. Ocul Immunol Inflamm 2007, 15:261-273.
30. Hosking M.P., Lane T.E. The biology of persistent infection: inflammation and demyelination following murine coronavirus infection of the central nervous system. Curr Immunol Rev 2009, 5:267-276.
31. Imitola J., Raddassi K., Park K.I., Mueller F.J., Nieto M., Teng Y.D., Frenkel D., Li J., Sidman R.L., Walsh C.A., Snyder E.Y., Khoury S.J. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 2004, 101:18,117-18,122.
32. Itoh T., Satou T., Ishida H., Nishida S., Tsubaki M., Hashimoto S., Ito H. The relationship between SDF-1alpha/CXCR4 and neural stem cells appearing in damaged area after traumatic brain injury in rats. Neurol Res 2009, 31:90-102.
33. Keirstead H.S., Nistor G., Bernal G., Totoiu M., Cloutier F., Sharp K., Steward O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005, 25:4694-4705.
34. Lane T.E., Buchmeier M.J. Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol 1997, 5:9-14.
35. Lane T.E., Liu M.T., Chen B.P., Asensio V.C., Samawi R.M., Paoletti A.D., Campbell I.L., Kunkel S.L., Fox H.S., Buchmeier M.J. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 2000, 74:1415-1424.
36. Lin M.T., Stohlman S.A., Hinton D.R. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol 1997, 71:383-391.
37. Liu M.T., Keirstead H.S., Lane T.E. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol 2001, 167:4091-4097.
38. Marten N.W., Stohlman S.A., Bergmann C.C. MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol 2001, 14:1-18.
39. Mason D.W., Charlton H.M., Jones A.J., Lavy C.B., Puklavec M., Simmonds S.J. The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents. Neuroscience 1986, 19:685-694.
40. Modo M., Rezaie P., Heuschling P., Patel S., Male D.K., Hodges H. Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response. Brain Res 2002, 958:70-82.
41. Nicholas M.K., Antel J.P., Stefansson K., Arnason B.G. Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J Immunol 1987, 139:2275-2283.
42. Nicholas M.K., Stefansson K., Antel J.P., Arnason B.G. An in vivo and in vitro analysis of systemic immune function in mice with histologic evidence of neural transplant rejection. J Neurosci Res 1987, 18:245-257.
43. Nistor G.I., Totoiu M.O., Haque N., Carpenter M.K., Keirstead H.S. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 2005, 49:385-396.
44. Oksenberg J.R., Begovich A.B., Erlich H.A., Steinman L. Genetic factors in multiple sclerosis. Jama 1993, 270:2362-2369.
45. Parra B., Hinton D.R., Marten N.W., Bergmann C.C., Lin M.T., Yang C.S., Stohlman S.A. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999, 162:1641-1647.
46. Pearce B.D., Hobbs M.V., McGraw T.S., Buchmeier M.J. Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J Virol 1994, 68:5483-5495.
47. Perlman S.R., Lane T.E., Buchmeier M.J. Coronaviruses: hepatitis, peritonitis, and central nervous system disease. Effects of Microbes on the Immune System Vol. 1 1999, 331-348. Lippincott Williams & Wilkins, Philadelphia. M.W. Cunningham, R.S. Fujinami (Eds.).
48. Pluchino S., Gritti A., Blezer E., Amadio S., Brambilla E., Borsellino G., Cossetti C., Del Carro U., Comi G., t Hart B., Vescovi G., Martino G. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Ann Neurol 2009, 66:343-354.
49. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., Galli R., Del Carro U., Amadio S., Bergami A., Furlan R., Comi G., Vescovi A.L., Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003, 422:688-694.
50. Pluchino S., Zanotti L., Brini E., Ferrari S., Martino G. Regeneration and repair in multiple sclerosis: the role of cell transplantation. Neurosci Lett 2009, 456:101-106.
51. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., Martinello M., Cattalini A., Bergami A., Furlan R., Comi G., Constantin G., Martino G. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005, 436:266-271.
52. Poser C.M. The epidemiology of multiple sclerosis: a general overview. Ann Neurol 1994, 36(Suppl 2):S180-193.
53. Raine C.S. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 1994, 36(Suppl):S61-S72.
54. Rizvi S.A., Agius M.A. Current approved options for treating patients with multiple sclerosis. Neurology 2004, 63:S8-14.
55. Robertson N.J., Brook F.A., Gardner R.L., Cobbold S.P., Waldmann H., Fairchild P.J. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci U S A 2007, 104:20,920-20,925.
56. Sayer F.T., Kronvall E., Nilsson O.G. Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature. Spine J 2006, 6:335-343.
57. Sher F., Balasubramaniyan V., Boddeke E., Copray S. Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy. Curr Opin Neurol 2008, 21:607-614.
58. Sim F.J., Zhao C., Penderis J., Franklin R.J. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 2002, 22:2451-2459.
59. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747.
60. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996, 85:299-302.
61. Stiles L.N., Hosking M.P., Edwards R.A., Strieter R.M., Lane T.E. Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. Eur J Immunol 2006, 36:613-622.
62. Stohlman S.A., Bergmann C.C., Lin M.T., Cua D.J., Hinton D.R. CTL effector function within the central nervous system requires CD4+ T cells. J Immunol 1998, 160:2896-2904.
63. Swijnenburg R.J., Schrepfer S., Govaert J.A., Cao F., Ransohoff K., Sheikh A.Y., Haddad M., Connolly A.J., Davis M.M., Robbins R.C., Wu J.C. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A 2008, 105:12,991-12,996.
64. Tepavcevic V., Blakemore W.F. Haplotype matching is not an essential requirement to achieve remyelination of demyelinating CNS lesions. Glia 2006, 54:880-890.
65. Totoiu M.O., Nistor G.I., Lane T.E., Keirstead H.S. Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp Neurol 2004, 187:254-265.
66. Tran P.B., Banisadr G., Ren D., Chenn A., Miller R.J. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J Comp Neurol 2007, 500:1007-1033.
67. van der Meulen A.A., Biber K., Lukovac S., Balasubramaniyan V., den Dunnen W.F., Boddeke H.W., Mooij J.J. The role of CXC chemokine ligand (CXCL)12-CXC chemokine receptor (CXCR)4 signalling in the migration of neural stem cells towards a brain tumour. Neuropathol Appl Neurobiol 2009, 35:579-591.
68. Weiner L.P. Pathogenesis of demyelination induced by a mouse hepatitis. Arch Neurol 1973, 28:298-303.
69. Whitman L., Zhou H., Perlman S., Lane T.E. IFN-gamma-mediated suppression of coronavirus replication in glial-committed progenitor cells. Virology 2009, 384:209-215.
70. Williamson J.S., Stohlman S.A. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol 1990, 64:4589-4592.
71. Williamson J.S., Sykes K.C., Stohlman S.A. Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J Neuroimmunol 1991, 32:199-207.
72. Wolswijk G., Noble M. Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells. J Cell Biol 1992, 118:889-900.
73. Wu G.F., Dandekar A.A., Pewe L., Perlman S. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 2000, 165:2278-2286.
74. Wu G.F., Perlman S. Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol 1999, 73:8771-8780.